The Brattleboro rat with hereditary hypothalamic diabetes insipidus.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000818:Animals; D001581:Benzothiadiazines; D002747:Chlorpropamide / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D003919:Diabetes Insipidus / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology*; D004195:Disease Models, Animal; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics; D005260:Female; D007031:Hypothalamus / Q000503:physiopathology*; D008297:Male; D010903:Pituitary Gland, Anterior / Q000503:physiopathology; D051381:Rats; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology; D013961:Thyroid Gland / Q000503:physiopathology; D014667:Vasopressins / Q000172:deficiency / Q000494:pharmacology / Q000502:physiology; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy / Q000503:physiopathology
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D002747:Chlorpropamide